Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery

JAMA

Volumn 307, Issue 21, 2012, Pages 2295-2304

  Devereaux, P J ^a   Chan, Matthew T V ^a   Alonso Coello, Pablo ^a   Walsh, Michael ^a   Berwanger, Otavio ^a   Villar, Juan Carlos ^a   Wang, C Y ^a   Garutti, R Ignacio ^a   Jacka, Michael J ^a   Sigamani, Alben ^a   Srinathan, Sadeesh ^a   Biccard, Bruce M ^a   Chow, Clara K ^a   Abraham, Valsa ^a   Tiboni, Maria ^a   Pettit, Shirley ^a   Szczeklik, Wojciech ^a   Buse, Giovanna Lurati ^a   Botto, Fernando ^a   Guyatt, Gordon ^a   Heels Ansdell, Diane ^a   Sessler, Daniel I ^a   Thorlund, Kristian ^a   Garg, Amit X ^a   Mrkobrada, Marko ^a   Thomas, Sabu ^a   Rodseth, Reitze N ^a   Pearse, Rupert M ^a   Thabane, Lehana ^a   McQueen, Matthew J ^a   VanHelder, Tomas ^a   Bhandari, Mohit ^a   Bosch, Jackie ^a   Kurz, Andrea ^a   Polanczyk, Carisi ^a   Malaga, German ^a   Nagele, Peter ^a   Le Manach, Yannick ^a   Leuwer, Martin ^a   Yusuf, Salim ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SURGICAL MORTALITY; SURGICAL PATIENT;

EID: 84861842161     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.5502     Document Type: Article

References (29)

1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery. Lancet. 2008;372(9633):139-144.
2. Devereaux PJ, Chan M, Eikelboom J. Major vascular complications in patients undergoing noncardiac surgery: the magnitude of the problem, risk prediction, surveillance, and prevention. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence-Based Cardiology. 3rd ed. London, England: BMJ Books; 2009:47-62.
3. Devereaux PJ, Yang H, Yusuf S, et al POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial. Lancet. 2008;371(9627):1839-1847.
4. Ford MK, Beattie WS, Wijeysundera DN. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med. 2010;152(1):26-35.
5. Gordon HS, Johnson ML, Wray NP, et al. Mortality after noncardiac surgery: prediction from administrative versus clinical data. Med Care. 2005;43(2):159-167. (Pubitemid 40222634)
6. Kim LJ, Martinez EA, Faraday N, et al. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation. 2002;106(18):2366-2371. (Pubitemid 35244739)
7. Le Manach Y, Perel A, Coriat P, Godet G, Bertrand M, Riou B. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology. 2005;102(5):885-891. (Pubitemid 40590068)
8. Mazumdar M, Smith A, Bacik J. Methods for categorizing a prognostic variable in amultivariable setting. Stat Med. 2003;22(4):559-571. (Pubitemid 36204178)
9. Hougaard P. Shared Frailty Models. Analysis of Multivariate Survival Data: Statistics for Biology and Health. New York, NY: Springer; 2000:215-262.
10. Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95(18):1404-1413. (Pubitemid 37220460)
11. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122(5):904-914. (Pubitemid 16207356)
12. Parzen M, Lipsitz SR. A global goodness-of-fit statistic for Cox regression models. Biometrics. 1999;55(2):580-584. (Pubitemid 29302586)
13. May S, Hosmer DW. A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal. 1998;4(2):109-120. (Pubitemid 128480552)
14. Kremers WK. Concordance for survival time data: fixed and time-dependent covariates and possible ties in predictor and time. Rochester, MN: Mayo Clinic; 2007. Technical Report Series #80.
15. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker. Stat Med. 2008;27(2):157-172.
16. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease. Kidney Int. 2005;67(6):2089-2100.
17. Levey AS, Stevens LA, Schmid CH, et al CKDEPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
18. Derksen S, Keselman H. Backward, forward and stepwise automated subset selection algorithms. Br J Math Stat Psychol. 1992;45:265-282 doi:10.1111/j.2044-8317.1992.tb00992.x.
19. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modeling with logistic regression analysis. Med Decis Making. 2001;21(1):45-56.
20. Kline R. Data preparation and screening. In: Kline R, ed. Principles and Practice of Structural Equation Modeling. New York, NY: The Guilford Press; 1998:67-94.
21. Aviles RJ, Askari AT, Lindahl B, et al. Troponin T levels in patientswith acute coronary syndromes,with or without renal dysfunction. N Engl J Med. 2002;346(26):2047-2052. (Pubitemid 34680596)
22. Levy M, Heels-Ansdell D, Hiralal R, et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery. Anesthesiology. 2011;114(4):796-806.
23. Thygesen K, Alpert JS, White HD, et al; Joint ESC /ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634-2653.
24. Panteghini M, Pagani F, Yeo KT, et al Committee on Standardization of Markers of Cardiac Damage of the IFCC. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem. 2004;50(2):327-332. (Pubitemid 38156373)
25. Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation. 2000;102(11):1216-1220.
26. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71-86.
27. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments. J AmColl Cardiol. 2008;52(22):1769-1781.
28. Devereaux PJ, Xavier D, Pogue J, et al POISE (Peri- Operative ISchemic Evaluation) Investigators. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery. Ann Intern Med. 2011;154(8):523-528.
29. Qaseem A, Snow V, Fitterman N, et al Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery. Ann Intern Med. 2006;144(8):575-580. (Pubitemid 46768148)